Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2013 /
Treatment decision making, screening and palliative care

3rd - 6th Nov 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.11.13
Views: 2751

Dr Jane Seymour - Nottingham University, UK

Dr Jane Seymour gives a comment to ecancertv at the UK's National Cancer Research Institute ( NCRI ) 2013 meeting on a session which she chaired looking at the latest in treatment decision making for oncologists and patients, screening, and palliative care. 

The session included:

- Modafinil for fatigue in lung cancer: multicentre, randomised, double-blinded, placebo-controlled trial: effect, dose response and patient satisfaction

- Results from the UNBIASED study (UK – Netherlands – Belgium International SEDation study) : reported practices of physicians and nurses in three European countries

- An all-Ireland population-based study of past and current physical and psychological side-effects following prostate cancer treatments

- Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme

- Clinical implications of a prostate cancer risk SNP profile in 2 treatment cohorts

- Over or under treatment? A systematic review and meta-analysis of factors determining change of management in active surveillance for localised prostate cancer

- Obesity and the outcome of young breast cancer patients in the UK: The POSH study

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation